Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: Neuromuscul Disord. 2014 Feb 10;24(5):431–435. doi: 10.1016/j.nmd.2014.01.014

Table 1.

Clinical Summary of the Patients

Clinical Presentation III-3 IV-6
Proximal atrophy + +
DTR patella/ankle 0/0 trace/0
Deltoid (L/R) 1–2/1–2 4+/4+
Biceps (L/R) 4−/4− 4/4
Triceps (L/R) 4−/4− 4+/4+
FDI (L/R) 4/4 5/5
EIP (L/R) 4/4 Not Tested
Hip flexors (L/R) 0–1/0–1 4−/4−
Hip extensors (L/R) 0–1/0–1 2/2
Knee flexors (L/R) 0/0 3+/3
Knee extensors (L/R) 1/1 4/4
Ankle dorsiflexion (L/R) 5/5 Limited by tight heel cords
Ankle plantarflexion (L/R) 4−/4− 4/4
Scapula winging + +
FVC (% predicted) 42 85
MIP (cm H2O) −60 −87
Creatine Kinase level (U/L) 181 3000